Furthermore, GP73, TGF‐β1 and Smad2 were highly expressed in bladder cancer and were associated with clinical features such as the clinical and pathological stages and LNMs of bladder cancer. The gene discussed is SMAD2; the disease is urinary bladder carcinoma.